JAMA PsychiatryJClub
Mental Health and Substance Use Disorder Expenditures in the US.
JAMA Psychiatry · · Journal Article · Open access
Blanco, McClellan + more
Abstract ↗AI summary
The abstract is read at the publisher; the summary is JClub's.
In the US civilian noninstitutionalized population with outpatient mental health visits, annual mental health spending totaled $174 billion (7.0% of all medical expenditures) in 2021–2023.
- Why it matters: Mental health spending magnitude and how it is distributed across groups and services are not well characterized, limiting evidence for directing resources and assessing alignment with public health priorities.
- What they did: Using a cross-sectional analysis of the 2021–2023 Medical Expenditure Panel Survey, the study estimated overall and per-100-person mental health expenditures by sociodemographics, insurance type, diagnostic categories, and service type among people with at least 1 outpatient mental health visit.
- The result: Mood disorders ($74 billion) and anxiety and fear-related disorders ($69 billion) had the highest aggregate expenditures, while per treated individual spending was highest for substance use disorders ($9569), schizophrenia ($9370), and bipolar disorders ($7382), with ambulatory services ($107 billion) the largest service category.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.
- Open access
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.